1. Home
  2. PCG vs ZTS Comparison

PCG vs ZTS Comparison

Compare PCG & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacific Gas & Electric Co.

PCG

Pacific Gas & Electric Co.

N/A

Current Price

$13.25

Market Cap

37.9B

Sector

Utilities

ML Signal

N/A

Logo Zoetis Inc.

ZTS

Zoetis Inc.

N/A

Current Price

$83.62

Market Cap

33.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PCG
ZTS
Founded
1995
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9B
33.5B
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
PCG
ZTS
Price
$13.25
$83.62
Analyst Decision
Buy
Hold
Analyst Count
18
16
Target Price
$17.62
★ $89.69
AVG Volume (30 Days)
★ 27.5M
4.1M
Earning Date
10-22-2026
11-05-2026
Dividend Yield
1.54%
★ 2.56%
EPS Growth
2.61
★ 10.05
EPS
0.72
★ 4.51
Revenue
★ $24,935,000,000.00
$9,467,000,000.00
Revenue This Year
$3.81
N/A
Revenue Next Year
$4.14
$0.54
P/E Ratio
★ $18.03
$18.38
Revenue Growth
2.11
★ 2.28
52 Week Low
$11.77
$68.92
52 Week High
$19.16
$132.49

Technical Indicators

Market Signals
Indicator
PCG
ZTS
Relative Strength Index (RSI) 51.61 58.55
Support Level $12.54 $71.78
Resistance Level $13.60 $89.29
Average True Range (ATR) 0.33 2.63
MACD 0.02 -0.08
Stochastic Oscillator 47.34 54.49

Price Performance

Historical Comparison
PCG
ZTS

About PCG Pacific Gas & Electric Co.

PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.7 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision in 2001-04 during California's energy crisis and in 2019-20 due to wildfire losses. In 2004, PG&E sold its unregulated assets as part of its first postbankruptcy reorganization.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: